https://www.gosh.nhs.uk/patients-and-families/support-services/gosh-arts/gosh-arts-news/temporary-tattoo-project/
The Temporary Tattoo Project
1 Sep 2017, 4:42 p.m.
Artist Davina Drummond worked with young people at Great Ormond Street Hospital (GOSH) to playfully explore and share what it means to be a young person in hospital.
Young people from wards across GOSH experimented with text and symbolism to create their own temporary tattoo designs. Davina and illustrator Ella Bell then worked together to turn the young people’s concepts into a limited edition set of eight temporary tattoos.
Historically tattoos have served as decorations for bravery, pledges of love and hope, celebrations of achievement and as reminders of important events, all themes that have been explored during the project. The temporary nature of the tattoos acts as a reminder that not all experiences or situations, especially when in hospital, are permanent.
The discussions and artworks that came out of the project have allowed young people to reflect on the techniques they use to cope with their illness, process their hospital experience and share the challenges they face as young people in hospital.
If you are a young person at GOSH or work with young people in the hospital then get in touch via the link below to claim your own set of GOSH Temporary Tattoos.
Our new strategy has launched: Together We Power Care
We’re proud to share our new Trust Strategy for Great Ormond Street Hospital for Children, TOGETHER WE POWER CARE. This is our vision for the future, and the steps we’ll take to achieve our ambitions of delivering life-changing care for our children.
GOSH contributes to landmark UAE-UK paper on AI in healthcare
We're proud to have contributed to a new paper published by the UAE-UK Business Council, exploring future opportunities for collaboration in artificial intelligence (AI) in healthcare between the United Kingdom and the United Arab Emirates.
Landmark gene therapy study shows safety for children
Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment.